What is the share price of Jeena Sikho Lifecare Ltd (JSLL) today?
The share price of JSLL as on 24th July 2026 is ₹554.80. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Jeena Sikho Lifecare Ltd (JSLL) share?
The past returns of Jeena Sikho Lifecare Ltd (JSLL) share are- Past 1 week: -3.78%
- Past 1 month: -4.59%
- Past 3 months: -12.45%
- Past 6 months: -15.93%
- Past 1 year: 4.37%
- Past 3 years: 692.57%
- Past 5 years: 2780.58%
What are the peers or stocks similar to Jeena Sikho Lifecare Ltd (JSLL)?
The peers or stocks similar to Jeena Sikho Lifecare Ltd (JSLL) include:What is the dividend yield % of Jeena Sikho Lifecare Ltd (JSLL) share?
The current dividend yield of Jeena Sikho Lifecare Ltd (JSLL) is 0.81.What is the market cap of Jeena Sikho Lifecare Ltd (JSLL) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Jeena Sikho Lifecare Ltd (JSLL) is ₹6896.20 Cr as of 24th July 2026.What is the 52 week high and low of Jeena Sikho Lifecare Ltd (JSLL) share?
The 52-week high of Jeena Sikho Lifecare Ltd (JSLL) is ₹849.50 and the 52-week low is ₹492.What is the PE and PB ratio of Jeena Sikho Lifecare Ltd (JSLL) stock?
The P/E (price-to-earnings) ratio of Jeena Sikho Lifecare Ltd (JSLL) is 31.08. The P/B (price-to-book) ratio is 25.26.Which sector does Jeena Sikho Lifecare Ltd (JSLL) belong to?
Jeena Sikho Lifecare Ltd (JSLL) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Jeena Sikho Lifecare Ltd (JSLL) shares?
You can directly buy Jeena Sikho Lifecare Ltd (JSLL) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Jeena Sikho Lifecare Ltd
JSLL Share Price
NSE₹554.800.89% (-5.00)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
JSLL Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
HighStrong financials and growth story over the years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
JSLL Performance & Key Metrics
JSLL Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 31.09 | 25.26 | 0.81% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 44.74 | 5.90 | 0.53% |
100%
Analysts have suggested that investors can buy this stock
from 1 analyst
Price Upside
Earnings Growth
Rev. Growth
JSLL Company Profile
Jeena Sikho Lifecare is engaged in developing health care products and providing ayurvedic healthcare services in India.
SUNPHARMA
PE Ratio
40.57
40.57
1Y Return
14.72%
14.72%
Buy Reco %
93.75
93.75
TORNTPHARM
PE Ratio
87.23
87.23
1Y Return
40.96%
40.96%
Buy Reco %
78.57
78.57
CIPLA
PE Ratio
29.38
29.38
1Y Return
5.20%
5.20%
Buy Reco %
66.67
66.67
ZYDUSLIFE
PE Ratio
21.94
21.94
1Y Return
14.15%
14.15%
Buy Reco %
55.17
55.17
LUPIN
PE Ratio
20.32
20.32
1Y Return
22.10%
22.10%
Buy Reco %
55.56
55.56
JSLL Sentiment Analysis
JSLL Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
JSLL Stock Summary · June 2026
Management framed FY26 as a year of strong growth and margin expansion while prioritizing rapid capacity scaling and commercialization of preventive‑Ayurveda offerings. Revenue reached INR 801 crore and EBITDA rose to INR 349 crore, driven by a high‑margin product portfolio and hub‑and‑spoke clinical rollouts, and management struck an upbeat, execution‑focused tone around expanding bed capacity, building a large research backend, and accelerating demand‑generation through marketing and new product launches. They acknowledged tension from discrete accounting and one‑time items—roughly INR 19–21 crore of Q4 provisions (bonuses, lease/gratuity, health‑card costs) and auditor‑driven timing changes to patient advances—that compressed reported quarterly comparability (management noted excluding the extraordinary items would lift FY26 EBITDA margin to about 46%). Operationally, bed activation is being staged to match demand and policy readiness: near term they expect ~2,800–3,000 operational beds in 3–4 months, aim for 3,000–3,500 by March 31 and see Ayushman/cashless implementation in about 1–2 months.
JSLL Stock Growth Drivers
JSLL Stock Growth Drivers
10Marked FY26 Financial Outperformance and Strong Balance Sheet
Jeena Sikho delivered material financial improvement in FY26, reporting revenue of INR 801 crore (up
Rapid Volume Growth and Improving Utilization
Operational demand accelerated sharply in FY26 with IPD volumes up 65% to 40,450 and OPD
JSLL Stock Challenges
JSLL Stock Challenges
6Material one-time provisions and charges depressed Q4 earnings
The quarter included significant discrete charges that materially reduced reported Q4 profit and created volatility
Accounting and auditor-driven recognition changes causing timing mismatches and provisioning risk
A change in accounting practice driven by the new auditor and Ind AS implementation altered
JSLL Forecast
JSLL Forecasts
Price
Revenue
Earnings
JSLL Share Price Forecast
JSLL Share Price Forecast
2026
Current
₹554.80
Baseline
Forecast for Jul 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
2026
Current
₹554.80
Baseline
Forecast for Jul 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
JSLL Company Revenue Forecast
JSLL Company Revenue Forecast
2026
Current
₹809.86
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹ cr.
2026
Current
₹809.86
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹ cr.
JSLL Stock EPS (Earnings Per Share) Forecast
JSLL Stock EPS (Earnings Per Share) Forecast
2026
Current
₹17.84
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
2026
Current
₹17.84
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
JSLL
JSLL
Income
Balance Sheet
Cash Flow
Quarterly Normal View
JSLL Income Statement
JSLL Income Statement
Quarterly Normal View
| Quarter | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 102.67 | 117.54 | 116.08 | 139.52 | 175.35 | 191.29 | 224.25 | 218.97 | ||||||||
Operating & Other expenses | 75.09 | 73.82 | 86.08 | 93.48 | 95.53 | 97.82 | 120.96 | 137.63 | ||||||||
EBITDA | 27.58 | 43.72 | 30.00 | 46.04 | 79.82 | 93.47 | 103.29 | 81.34 | ||||||||
| Depreciation/Amortization | 5.36 | 6.25 | 8.47 | 9.03 | 9.65 | 10.40 | 11.26 | 16.38 | ||||||||
| PBIT | 22.22 | 37.47 | 21.53 | 37.01 | 70.17 | 83.07 | 92.03 | 64.96 | ||||||||
| Interest & Other Items | 1.70 | 2.07 | 3.79 | 3.10 | 1.66 | 4.35 | 3.10 | 3.73 | ||||||||
| PBT | 20.52 | 35.40 | 17.74 | 33.91 | 68.51 | 78.72 | 88.93 | 61.23 | ||||||||
| Taxes & Other Items | 4.79 | 8.81 | 4.53 | 8.58 | 17.24 | 19.97 | 22.27 | 16.09 | ||||||||
| Net Income | 15.73 | 26.59 | 13.21 | 25.33 | 51.27 | 58.75 | 66.66 | 45.14 | ||||||||
| EPS | 0.25 | 0.43 | 0.21 | 0.41 | 4.12 | 4.73 | 5.36 | 3.63 |
JSLL Company Updates
JSLL Stock Peers
JSLL Past Performance & Peer Comparison
JSLL Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Jeena Sikho Lifecare Ltd | 31.08 | 25.26 | 0.81% |
| Sun Pharmaceutical Industries Ltd | 40.57 | 5.55 | 0.82% |
| Torrent Pharmaceuticals Ltd | 87.23 | 10.73 | 0.68% |
| Cipla Ltd | 29.38 | 3.30 | 0.92% |
JSLL Stock Price Comparison
Compare JSLL with any stock or ETFCompare JSLL with any stock or ETF
JSLL
JSLL Holdings
JSLL Shareholdings
JSLL Promoter Holdings Trend
JSLL Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
JSLL Institutional Holdings Trend
JSLL Institutional Holdings Trend
Increased Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has increased by 2.76%
Decreased Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has decreased by 1.38%
JSLL Shareholding Pattern
JSLL Shareholding Pattern
JSLL Shareholding History
JSLL Shareholding History
Foreign Institutions
Mutual Funds Invested in JSLL
Mutual Funds Invested in JSLL
No mutual funds holding trends are available
Top 5 Mutual Funds holding Jeena Sikho Lifecare Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 0.1069% | Percentage of the fund’s portfolio invested in the stock 0.30% | Change in the portfolio weight of the stock over the last 3 months -0.07% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 217/255 (-46) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0007% | Percentage of the fund’s portfolio invested in the stock 0.01% | Change in the portfolio weight of the stock over the last 3 months -0.00% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 692/755 (-24) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0001% | Percentage of the fund’s portfolio invested in the stock 0.01% | Change in the portfolio weight of the stock over the last 3 months -0.00% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 682/757 (-34) |
Compare 3-month MF holding change on Screener
smallcases containing JSLL stock
smallcases containing JSLL stock
Looks like this stock is not in any smallcase yet.
JSLL Events
JSLL Events
JSLL Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
JSLL Dividend Trend
No dividend trend available
JSLL Upcoming Dividends
JSLL Upcoming Dividends
No upcoming dividends are available
JSLL Past Dividends
JSLL Past Dividends
Cash Dividend
Ex DateEx DateSep 22, 2025
Final
Final | Div/Share: ₹1.10
Dividend/Share
₹1.10
Ex DateEx Date
Sep 22, 2025
Cash Dividend
Ex DateEx DateAug 20, 2024
Final
Final | Div/Share: ₹4.18
Dividend/Share
₹4.18
Ex DateEx Date
Aug 20, 2024
Cash Dividend
Ex DateEx DateAug 25, 2023
Final
Final | Div/Share: ₹2.00
Dividend/Share
₹2.00
Ex DateEx Date
Aug 25, 2023
JSLL Stock News & Opinions
JSLL Stock News & Opinions
Articles & Videos
Spotlight
Spotlight
Jeena Sikho Lifecare Ltd leads gainers in 'B' groupThacker & Company Ltd, HLE Glascoat Ltd, SKM Egg Products Export (India) Ltd and HCL Infosystems Ltd are among the other gainers in the BSE's 'B' group today, 02 June 2026.Jeena Sikho Lifecare Ltd surged 16.35% to Rs 573.1 at 12:01 IST. The stock was the biggest gainer in the BSE's 'B' group. On the BSE, 11.14 lakh shares were traded on the counter so far as against the average daily volumes of 46082 shares in the past one month. Thacker & Company Ltd soared 15.21% to Rs 1440.1. The stock was the second biggest gainer in 'B' group. On the BSE, 347 shares were traded on the counter so far as against the average daily volumes of 23 shares in the past one month. HLE Glascoat Ltd spiked 13.27% to Rs 362. The stock was the third biggest gainer in 'B' group. On the BSE, 51173 shares were traded on the counter so far as against the average daily volumes of 8835 shares in the past one month. SKM Egg Products Export (India) Ltd jumped 13.04% to Rs 233.15. The stock was the fourth biggest gainer in 'B' group. On the BSE, 3.72 lakh shares were traded on the counter so far as against the average daily volumes of 74654 shares in the past one month. HCL Infosystems Ltd advanced 12.45% to Rs 13.64. The stock was the fifth biggest gainer in 'B' group. On the BSE, 2.58 lakh shares were traded on the counter so far as against the average daily volumes of 58502 shares in the past one month. Powered by Capital Market - Live
1 month agoCapital Market - Live
Spotlight
Spotlight
Jeena Sikho Lifecare Ltd leads losers in 'B' groupArihant Foundations & Housing Ltd, Coastal Corporation Ltd, Birla Precision Technologies Ltd and RPP Infra Projects Ltd are among the other losers in the BSE's 'B' group today, 01 June 2026.Jeena Sikho Lifecare Ltd crashed 20.00% to Rs 491.95 at 14:31 IST.The stock was the biggest loser in the BSE's 'B' group.On the BSE, 2.95 lakh shares were traded on the counter so far as against the average daily volumes of 31843 shares in the past one month.Arihant Foundations & Housing Ltd lost 19.45% to Rs 735.55. The stock was the second biggest loser in 'B' group.On the BSE, 8628 shares were traded on the counter so far as against the average daily volumes of 4419 shares in the past one month.Coastal Corporation Ltd tumbled 17.77% to Rs 49.78. The stock was the third biggest loser in 'B' group.On the BSE, 31753 shares were traded on the counter so far as against the average daily volumes of 12772 shares in the past one month.Birla Precision Technologies Ltd shed 16.05% to Rs 38.91. The stock was the fourth biggest loser in 'B' group.On the BSE, 1.18 lakh shares were traded on the counter so far as against the average daily volumes of 68697 shares in the past one month.RPP Infra Projects Ltd dropped 14.21% to Rs 64.66. The stock was the fifth biggest loser in 'B' group.On the BSE, 17874 shares were traded on the counter so far as against the average daily volumes of 5902 shares in the past one month.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Corporate
Board of Jeena Sikho Lifecare recommends final dividendJeena Sikho Lifecare announced that the Board of Directors of the Company at its meeting held on 30 May 2026, inter alia, have recommended the final dividend of Rs 4.5 per equity Share (i.e. 225%) , subject to the approval of the shareholders.
1 month agoCapital Market - Live
Earnings
Earnings
Jeena Sikho Lifecare consolidated net profit rises 78.10% in the March 2026 quarterNet profit of Jeena Sikho Lifecare rose 78.10% to Rs 45.13 crore in the quarter ended March 2026 as against Rs 25.34 crore during the previous quarter ended March 2025. Sales rose 54.79% to Rs 215.55 crore in the quarter ended March 2026 as against Rs 139.25 crore during the previous quarter ended March 2025. For the full year,net profit rose 177.52% to Rs 221.85 crore in the year ended March 2026 as against Rs 79.94 crore during the previous year ended March 2025. Sales rose 70.84% to Rs 801.36 crore in the year ended March 2026 as against Rs 469.07 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales215.55139.25 55 801.36469.07 71 OPM %36.1532.87 -43.6029.97 - PBDT77.6142.94 81 345.09136.68 152 PBT61.2333.92 81 297.39107.58 176 NP45.1325.34 78 221.8579.94 178 Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Corporate
Jeena Sikho Lifecare announces board meeting dateJeena Sikho Lifecare will hold a meeting of the Board of Directors of the Company on 30 May 2026.
2 months agoCapital Market - Live
Corporate
Corporate
Jeena Sikho Lifecare receives NABH accreditation for its Noida HospitalJeena Sikho Lifecare has been awarded the National Accreditation Board for Hospitals & Healthcare Providers (NABH) Certificate of Accreditation for its Noida Hospital.
3 months agoCapital Market - Live
Corporate
Corporate
Jeena Sikho Lifecare receives NABH accreditation for Dehradun HospitalJeena Sikho Lifecare has been awarded the National Accreditation Board for Hospitals & Healthcare Providers (NABH) Certificate of Accreditation for its Dehradun Hospital. The receipt of this NABH accreditation signifies adherence to nationally recognized standards for quality healthcare delivery, patient safety, and operational excellence. This development has occurred in the ordinary course of business and does not constitute business expansion, capacity enhancement, or acquisition.Powered by Capital Market - Live
5 months agoCapital Market - Live
Earnings
Earnings
Jeena Sikho Lifecare standalone net profit rises 405.15% in the December 2025 quarterNet profit of Jeena Sikho Lifecare rose 405.15% to Rs 66.73 crore in the quarter ended December 2025 as against Rs 13.21 crore during the previous quarter ended December 2024. Sales rose 91.60% to Rs 221.66 crore in the quarter ended December 2025 as against Rs 115.69 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales221.66115.69 92 OPM %45.4825.59 - PBDT100.2726.21 283 PBT89.0617.74 402 NP66.7313.21 405 Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Corporate
Jeena Sikho Lifecare announces board meeting dateJeena Sikho Lifecare will hold a meeting of the Board of Directors of the Company on 7 February 2026.Powered by Capital Market - Live
5 months agoCapital Market - Live
Earnings
Earnings
Jeena Sikho Lifecare standalone net profit rises 121.02% in the September 2025 quarterNet profit of Jeena Sikho Lifecare rose 121.02% to Rs 58.79 crore in the quarter ended September 2025 as against Rs 26.60 crore during the previous quarter ended September 2024. Sales rose 66.40% to Rs 189.85 crore in the quarter ended September 2025 as against Rs 114.09 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales189.85114.09 66 OPM %48.5035.31 - PBDT89.1641.66 114 PBT78.7635.41 122 NP58.7926.60 121 Powered by Capital Market - Live
8 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 42.7%, vs industry avg of 12.48%
Over the last 5 years, market share increased from 0.05% to 0.16%
Over the last 5 years, net income has grown at a yearly rate of 84.78%, vs industry avg of 10.55%